Because DUSP26 is a novel therapeutic target for the treatment of neuroblastomas and pediatric malignancies, the crystal structure of DUSP26-N (C152S) will be useful for the rational design of novel DUSP26-targeting anticancer therapeutics. This evidence concerns the gene DUSP26 and neuroblastoma.